Newsmeme!
Discover News you didn't know existed
Sinus Rhythm
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
If He Goes, I Go Too
Published September 3, 2008, 12:13 pm, San Diego Reader
It seemed as if everyone who worked at our local hospital knew Jake. A self-proclaimed “recovered hater of doctors,” he became a fixture, volunteering in the emergency room.
A New Frontier In Cardiovascular Medicine: Transcatheter Aortic Valve Replacement
Published September 3, 2008, 5:10 am, Medical News Today
Current experiences with one of the two CE Marked devices, the CoreValve ReValving® System for Percutaneous Aortic Valve Replacement (PAVR) have proved to be an overall success. This device consists of a porcine pericardial valve prosthesis mounted on a self-expanding Nitonol frame, which is delivered by means of an 18 French size (6mm) catheter.
Transcatheter aortic valve replacement -- a new frontier in cardiovascular medicine
Published September 2, 2008, 7:46 am, EurekAlert!
Replacing heart valves without the substantial trauma of opening the chest and the heart were little known concepts until the groundbreaking pulmonary and aortic transcatheter valve replacements performed during 2000 and 2002, respectively by Philipp Bonhoeffer and Alain Cribier. Today, advanced development programs for less invasive treatment of the aortic, mitral and pulmonary valves are ...
Transcatheter Aortic Valve Replacement A New Frontier In Cardiovascular Medicine
Published September 2, 2008, 4:11 am, Medical News Today
Replacing heart valves without the substantial trauma of opening the chest and the heart were little known concepts until the groundbreaking pulmonary and aortic transcatheter valve replacements performed during 2000 and 2002, respectively by Philipp Bonhoeffer and Alain Cribier.
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate ...
Published September 2, 2008, 3:10 am, Medical News Today
The ERATO study published in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean heart rate reduction was 11.7 beats per minute (phttp://www.chu-montpellier.fr/fr/index.
Dronedarone (Multaq(R)) Improves Ventricular Rate Control In Patients With Permanent Atrial Fibrillation - ERATO Study
Published September 1, 2008, 6:09 am, Medical News Today
The ERATO study published in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean heart rate reduction was 11.
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate ...
Published August 31, 2008, 11:02 pm, Thaipr.net
The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 2
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate ...
Published August 31, 2008, 9:58 pm, FinanzNachrichten
Montpellier, France (ots/PRNewswire) - The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with ...
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate ...
Published August 31, 2008, 9:42 pm, Presseportal
Montpellier, France (ots/PRNewswire) - The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces ...
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate ...
Published August 31, 2008, 9:30 pm, CNW Group via Yahoo! Finance
The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |